USCarePharm Expands R&D for Functional Pharmaceutical and Nutraceutical Ingredients Derived from Natural and Bio-Based Materials

USCarePharm Co., Ltd., a specialized company in the development of high-performance functional materials, announced plans to expand its business into the development of functional pharmaceutical actives and health supplement ingredients, leveraging both natural products and bio-based technologies.

Founded in 2016, USCarePharm brings together more than two decades of pharmaceutical expertise and has built a proprietary platform for developing functional materials derived from natural sources.
The company has recently identified promising compounds, including USCP0107, a natural ingredient shown to alleviate functional dyspepsia by inhibiting gastric mucosal inflammation, and USCP0112, which supports vascular wall health. Both candidates are currently progressing rapidly toward commercialization.

Targeting chronic digestive and vascular conditions, USCarePharm is committed to developing safe and efficacious bioactive ingredients to support the development of health functional foods and functional therapeutics.

CEO Song Seok-jin commented:

“We have accumulated proprietary know-how in discovering and commercializing functional materials from natural sources.
Our latest bio-based ingredients have been standardized and optimized for industrial use, and we are poised to scale up commercialization.
We also plan to strengthen collaboration with domestic and international research institutes to further advance the development of functional therapeutic foods and biopharmaceuticals.”

With its solid foundation in bio-convergent R&D and natural product science, USCarePharm aims to become a key innovator in the functional healthcare sector.

Source: IBabyNews
© IBabyNews. Unauthorized reproduction or redistribution is strictly prohibited.